by Team Small News | Nov 12, 2025 | Cipla, Natco, Pharma
Cipla, Natco, Hetero, and Annora, four prominent Indian pharmaceutical companies, have secured significant contracts to supply generic drugs to China. This development marks a major breakthrough for Indian pharmaceutical companies in the Chinese market. The contracts... by Team Small News | Nov 4, 2025 | Natco, Pharma
The Delhi High Court recently delivered a significant judgment in the case of F. Hoffmann-La Roche Ag & Anr. vs. Natco Pharma, which has far-reaching implications for the pharmaceutical industry. The court’s ruling pertains to the interpretation of Section... by Team Small News | Oct 24, 2025 | Natco, Pharma
NATCO Pharma Limited is an Indian pharmaceutical company that has been facing challenges in maintaining stable cash flow during market downturns. According to recent statistics, the company’s cash flow has been volatile, with significant fluctuations in its... by Team Small News | Oct 20, 2025 | Natco, Pharma
The Supreme Court of India has rejected a plea by Swiss pharmaceutical company F. Hoffmann-La Roche AG (Roche) to restrain Natco Pharma Ltd from selling a generic version of its life-saving spinal muscular atrophy (SMA) drug, Risdiplam, in India. The court upheld a... by Team Small News | Oct 11, 2025 | Natco, Pharma
India’s Natco Pharma has announced a significant investment in South Africa’s 135-year-old pharmaceutical giant, Adcock Ingram. The R 4.2-billion deal will see Adcock Ingram become a privately-held entity co-owned by Natco and Bidvest, with Bidvest... by Team Small News | Sep 26, 2025 | Natco, Pharma
Natco Pharma, a generic drugmaker, is considering spinning off its agro business into a separate entity. The company’s board of directors has given in-principle approval for the demerger, which is expected to unlock value in the core pharmaceuticals business and...